# Mercadolibre Inc: overview

MELI · Nasdaq · CIK 1099590 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/meli.md) · [Financials](/companies/meli/financials.md) · [Filings](/companies/meli/filings.md) · [Insiders](/companies/meli/insiders.md)

Latest reported revenue: [$7.05bn](/filings/0001099590-26-000023.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001099590-26-000023).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,895](/filings/0001099590-25-000051.md) | [4,436 d](/filings/0001099590-26-000006.md) | [4,191](/filings/0001099590-26-000017.md) | [4,803](/filings/0001099590-26-000023.md) | [5,205](/filings/0001099590-25-000051.md) | [6,136 d](/filings/0001099590-26-000006.md) | [6,065](/filings/0001099590-26-000017.md) | [7,055](/filings/0001099590-26-000023.md) |
| Gross margin | % | [62.6%](/filings/0001099590-25-000051.md) | [62.0% d](/filings/0001099590-26-000006.md) | [66.1%](/filings/0001099590-26-000017.md) | [64.4%](/filings/0001099590-26-000023.md) | [61.7%](/filings/0001099590-25-000051.md) | [61.7% d](/filings/0001099590-26-000006.md) | [63.7%](/filings/0001099590-26-000017.md) | [59.0%](/filings/0001099590-26-000023.md) |
| Operating margin | % | [14.3%](/filings/0001099590-25-000051.md) | [18.5% d](/filings/0001099590-26-000006.md) | [18.2%](/filings/0001099590-26-000017.md) | [17.2%](/filings/0001099590-26-000023.md) | [13.9%](/filings/0001099590-25-000051.md) | [14.5% d](/filings/0001099590-26-000006.md) | [10.1%](/filings/0001099590-26-000017.md) | [9.7%](/filings/0001099590-26-000023.md) |
| Net margin | % | [10.2%](/filings/0001099590-25-000051.md) | [14.4% d](/filings/0001099590-26-000006.md) | [11.8%](/filings/0001099590-26-000023.md) | [10.9%](/filings/0001099590-26-000023.md) | [8.1%](/filings/0001099590-25-000051.md) | [9.1% d](/filings/0001099590-26-000006.md) | [6.9%](/filings/0001099590-26-000023.md) | [6.6%](/filings/0001099590-26-000023.md) |
| Diluted EPS | $ per share | [7.83](/filings/0001099590-25-000051.md) | not reported | [9.74](/filings/0001099590-26-000017.md) | [10.31](/filings/0001099590-26-000023.md) | [8.32](/filings/0001099590-25-000051.md) | not reported | [8.23](/filings/0001099590-26-000017.md) | [9.19](/filings/0001099590-26-000023.md) |
| Free cash flow | $m | [1,378 d](/filings/0001099590-25-000051.md) | [2,615 d](/filings/0001099590-26-000006.md) | [759](/filings/0001099590-26-000017.md) | [2,630 d](/filings/0001099590-26-000023.md) | [2,602 d](/filings/0001099590-25-000051.md) | [4,782 d](/filings/0001099590-26-000006.md) | [1,804](/filings/0001099590-26-000017.md) | [3,221 d](/filings/0001099590-26-000023.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.7](/filings/0001099590-24-000008.md) | [7.5](/filings/0001099590-25-000007.md) | [10.5](/filings/0001099590-26-000006.md) | [15.1](/filings/0001099590-26-000006.md) | [20.3](/filings/0001099590-26-000006.md) |
| Gross margin | % | [52.6%](/filings/0001099590-24-000008.md) | [69.8%](/filings/0001099590-25-000007.md) | [72.4%](/filings/0001099590-26-000006.md) | [63.3%](/filings/0001099590-26-000006.md) | [63.2%](/filings/0001099590-26-000006.md) |
| Operating margin | % | [7.7%](/filings/0001099590-24-000008.md) | [14.3%](/filings/0001099590-25-000007.md) | [21.0%](/filings/0001099590-26-000006.md) | [17.4%](/filings/0001099590-26-000006.md) | [15.7%](/filings/0001099590-26-000006.md) |
| Net margin | % | [1.5%](/filings/0001099590-24-000008.md) | [6.5%](/filings/0001099590-25-000007.md) | [9.4%](/filings/0001099590-26-000006.md) | [12.6%](/filings/0001099590-26-000006.md) | [9.8%](/filings/0001099590-26-000006.md) |
| Diluted EPS | $ per share | [1.67](/filings/0001099590-24-000008.md) | [9.53](/filings/0001099590-25-000007.md) | [19.46](/filings/0001099590-26-000006.md) | [37.69](/filings/0001099590-26-000006.md) | [39.40](/filings/0001099590-26-000006.md) |
| Free cash flow | $bn | [0.4](/filings/0001099590-24-000008.md) | [2.5](/filings/0001099590-25-000007.md) | [4.6](/filings/0001099590-26-000006.md) | [7.1](/filings/0001099590-26-000006.md) | [10.8](/filings/0001099590-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/meli/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $5.33bn | 3,138,040 |  | Added +420,868 |
| [BAILLIE GIFFORD & CO](/funds/1088875.md) | 2026-06-30 | $5.16bn | 3,040,410 |  | Reduced −192,849 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $3.18bn | 1,873,498 |  | Added +135,939 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $3.01bn | 1,773,692 |  | Reduced −420,789 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.54bn | 1,496,328 |  | Reduced −88,928 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $2.49bn | 1,469,899 |  | Added +1,069,289 |
| [EAGLE CAPITAL MANAGEMENT LLC](/funds/945631.md) | 2026-06-30 | $2.39bn | 1,406,953 |  | Added +621,016 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.25bn | 1,323,217 |  | Reduced −43,847 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.47bn | 863,100 | Put | Added +176,600 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.45bn | 857,100 | Call | Added +201,600 |

## Recent filings

[All 702 filings](/companies/meli/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 16:30 ET | [8-K](/filings/0001140361-26-036495.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-036495 |
| 2026-09-10 | 10:19 ET | [8-K](/filings/0001140361-26-036136.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036136 |
| 2026-08-06 | 18:15 ET | [10-Q](/filings/0001099590-26-000023.md) | Quarterly report, period 2026-06-30 | 0001099590-26-000023 |
| 2026-08-05 | 16:00 ET | [8-K](/filings/0001099590-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099590-26-000021 |
| 2026-06-18 | 16:39 ET | [SCHEDULE 13D/A](/filings/0001437749-26-021169.md) | Ownership report, active investor, amended | 0001437749-26-021169 |
| 2026-06-12 | 16:33 ET | [8-K](/filings/0001999371-26-012770.md) | 5.07 Shareholder vote results | 0001999371-26-012770 |
| 2026-05-08 | 16:03 ET | [10-Q](/filings/0001099590-26-000017.md) | Quarterly report, period 2026-03-31 | 0001099590-26-000017 |
| 2026-05-07 | 16:00 ET | [8-K](/filings/0001099590-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099590-26-000014 |
| 2026-04-23 | 16:02 ET | [DEF 14A](/filings/0001099590-26-000010.md) | Proxy statement, period 2026-06-09 | 0001099590-26-000010 |
| 2026-04-03 | 16:32 ET | [8-K](/filings/0001999371-26-007656.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001999371-26-007656 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001099590-26-000006.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c062decd-4e7e-449f-a8df-9c67ac8ba271)

## About the filer

- CIK: 1099590
- Tickers: MELI
- Exchange: Nasdaq
- SIC code: 7389 Services-Business Services, NEC
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.